A Randomized double-blind placebo controlled study to Evaluate Prophylactic effects of Silodosin on Postoperative Urinary Retention

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20191226003

Enrollment

268

Registered

2019-12-26

Start date

2019-08-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post&#45

Interventions

silodosin,placebo

Experimental Drug,Placebo Comparator Drug

prophylaxis,non&#45

prophylaxis

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: inguinal hernia patient

Exclusion criteria

Exclusion criteria: Indwelling foley cath before surgey

Design outcomes

Primary

Measure	Time frame
To evaluation prophylactic effects of silodosin on post operative urinary retension 24 hr after surgery no urinary retention	—

Secondary

Measure	Time frame
none none none	—

Countries

bankok

Contacts

Public ContactNarutsama pimpanit

Ramathibodhi hospital

n.pimpanit@mail.com0917745827

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

A Randomized double&#45;blind placebo controlled study to Evaluate Prophylactic effects of Silodosin on Postoperative Urinary Retention